VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:
- Biotechnology
- Chemicals
- Food processing
- Electronics
- Healthcare
- Pharmaceuticals
Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:
- Market segmentation
- Competitive landscape
- Regulatory policies
- Latest technology trends
- Acquisition evaluations
- Vendors’ analysis, etc.
Publications found:
60,074
Sort by:
Diagnostic Imaging Market Forecast 2017-2021: A Market in Transition Amid Regulatory Uncertainty and Intensifying Competition--X-ray, Ultrasound, MRI, CT, Nuclear Medicine, PET, PACS
US$ 3,850.00
... overview of the diagnostic imaging market includes the following:·Estimates of the market size and growth. ·Sales forecasts by geographic region ... etc. System service and support. Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, ...
December 2017
185 pages
US Cancer Diagnostics Market Segmentation Analysis 2017-2021: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 9,800.00
... tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
December 2017
620 pages
US Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2017-2021: Supplier Shares, Sales Forecasts by Test and Market Segment, Competitive Strategies, Technology Trends, Instrumentation Review
US$ 9,700.00
... potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist ... key suppliers. Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by market segment ...
December 2017
465 pages
Immunohematology and Infectious Disease NAT Screening Market: 2017 Supplier Sales and Market Shares by Country, Technology Review, and Strategic Profiles of Leading Suppliers
US$ 3,850.00
This 154-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and ...
December 2017
154 pages
Orthopedic Devices Market Forecast 2017-2021: Accelerated Rate of Change and Regulatory Uncertainty Confronting the Industry--Performance, Capabilities, Goals and Strategies of Leading Orthopedics Companies
US$ 3,850.00
... of the orthopedics market, including forecasts for major geographic regions, market segments and ... orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc. The analysis of major market segments, including reconstructive devices ...
December 2017
325 pages
Global Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2017-2021: France, Germany, Italy, Japan, Spain, UK, US--Supplier Shares, Sales Forecasts by Test and Market Segment, Competitive Strategies, Technology Trends, Instrumentation Review
US$ 35,500.00
... entrants identify and evaluate emerging opportunities in the global molecular blood banking market during the next five years, and ... country. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with ...
December 2017
775 pages
